Operating Income Summary of Formosa Laboratories, Inc.

Formosa Laboratories, Inc.'s latest annual operating income in 2023 was 674.97 Million TWD , up 77.23% from previous year.
Formosa Laboratories, Inc.'s latest quarterly operating income in 2024 Q2 was 166.27 Million TWD , down -11.43% from previous quarter.
Formosa Laboratories, Inc. reported an annual operating income of 380.84 Million TWD in 2022, down -65.43% from previous year.
Formosa Laboratories, Inc. reported an annual operating income of 1.1 Billion TWD in 2021, up 162.05% from previous year.
Formosa Laboratories, Inc. reported a quarterly operating income of 166.27 Million TWD for 2024 Q2, down -11.43% from previous quarter.
Formosa Laboratories, Inc. reported a quarterly operating income of 674.97 Million TWD for 2023 FY, up 77.23% from previous quarter.

Annual Operating Income Chart of Formosa Laboratories, Inc. (2023 - 2009)

Historical Annual Operating Income of Formosa Laboratories, Inc. (2023 - 2009)

Year	Operating Income	Operating Income Growth
2023	674.97 Million TWD	77.23%
2022	380.84 Million TWD	-65.43%
2021	1.1 Billion TWD	162.05%
2020	420.41 Million TWD	19123.35%
2019	-2.21 Million TWD	-103.86%
2018	57.23 Million TWD	-84.87%
2017	378.19 Million TWD	-42.99%
2016	663.42 Million TWD	103.77%
2015	325.57 Million TWD	18.85%
2014	273.94 Million TWD	465.04%
2013	-75.04 Million TWD	-302.94%
2012	36.97 Million TWD	-84.84%
2011	243.92 Million TWD	-24.08%
2010	321.29 Million TWD	0.0%
2009	- TWD	0.0%

Year	Operating Income	Operating Income Growth
2024 Q1	187.72 Million TWD	-20.21%
2024 Q2	166.27 Million TWD	-11.43%
2023 FY	674.97 Million TWD	77.23%
2023 Q4	235.28 Million TWD	366.21%
2023 Q3	-88.38 Million TWD	-189.14%
2023 Q2	99.15 Million TWD	327.74%
2023 Q1	-43.53 Million TWD	-112.6%
2022 Q3	501.49 Million TWD	1499.72%
2022 Q1	-430.44 Million TWD	-190.14%
2022 FY	380.84 Million TWD	-65.43%
2022 Q4	345.62 Million TWD	-31.08%
2022 Q2	-35.82 Million TWD	91.68%
2021 Q3	-51.81 Million TWD	27.67%
2021 Q2	-71.64 Million TWD	-2.08%
2021 FY	1.1 Billion TWD	162.05%
2021 Q1	-70.18 Million TWD	-165.16%
2021 Q4	-148.35 Million TWD	-186.32%
2020 Q2	-42.89 Million TWD	-61.78%
2020 Q3	20.44 Million TWD	147.66%
2020 FY	420.41 Million TWD	19123.35%
2020 Q1	-26.51 Million TWD	-151.39%
2020 Q4	107.7 Million TWD	426.83%
2019 Q2	-21.99 Million TWD	77.05%
2019 Q1	-95.84 Million TWD	-341.37%
2019 Q4	51.59 Million TWD	-48.4%
2019 Q3	99.97 Million TWD	554.45%
2019 FY	-2.21 Million TWD	-103.86%
2018 Q1	-1.18 Million TWD	-102.26%
2018 Q3	3.34 Million TWD	-78.25%
2018 Q4	39.7 Million TWD	1087.77%
2018 FY	57.23 Million TWD	-84.87%
2018 Q2	15.36 Million TWD	1393.6%
2017 Q3	57.36 Million TWD	-61.03%
2017 Q2	147.19 Million TWD	21.63%
2017 Q1	121.01 Million TWD	-19.69%
2017 FY	378.19 Million TWD	-42.99%
2017 Q4	52.62 Million TWD	-8.25%
2016 Q2	191.72 Million TWD	23.03%
2016 FY	663.42 Million TWD	103.77%
2016 Q3	165.17 Million TWD	-13.84%
2016 Q1	155.83 Million TWD	19.37%
2016 Q4	150.68 Million TWD	-8.77%
2015 Q4	130.55 Million TWD	54.99%
2015 Q2	41.72 Million TWD	-39.59%
2015 Q1	69.06 Million TWD	92.91%
2015 Q3	84.22 Million TWD	101.86%
2015 FY	325.57 Million TWD	18.85%
2014 Q1	48.64 Million TWD	-0.18%
2014 FY	273.94 Million TWD	465.04%
2014 Q4	35.8 Million TWD	-63.11%
2014 Q3	97.04 Million TWD	4.97%
2014 Q2	92.44 Million TWD	90.04%
2013 Q4	48.73 Million TWD	-3.51%
2013 Q1	-180.48 Million TWD	-681.9%
2013 Q2	6.2 Million TWD	103.44%
2013 FY	-75.04 Million TWD	-302.94%
2013 Q3	50.5 Million TWD	714.6%
2012 Q2	27.09 Million TWD	-25.4%
2012 Q1	36.31 Million TWD	-33.61%
2012 Q3	-3.66 Million TWD	-113.53%
2012 Q4	-23.08 Million TWD	-529.82%
2012 FY	36.97 Million TWD	-84.84%
2011 Q1	79.34 Million TWD	-75.3%
2011 Q4	54.7 Million TWD	-2.18%
2011 Q2	53.95 Million TWD	-32.0%
2011 Q3	55.91 Million TWD	3.64%
2011 FY	243.92 Million TWD	-24.08%
2010 Q4	321.29 Million TWD	0.0%
2010 Q1	- TWD	0.0%
2010 Q2	- TWD	0.0%
2010 FY	321.29 Million TWD	0.0%
2010 Q3	- TWD	0.0%
2009 FY	- TWD	0.0%

Peer Operating Income Comparison of Formosa Laboratories, Inc.

Name	Operating Income	Operating Income Difference
Grape King Bio Ltd	2.49 Billion TWD	72.965%
Standard Chem & Pharm CO., LTD.	1.25 Billion TWD	46.412%
Maywufa Company Ltd.	211.01 Million TWD	-219.865%
ScinoPharm Taiwan, Ltd.	314.49 Million TWD	-114.625%
Lotus Pharmaceutical Co., Ltd.	4.9 Billion TWD	86.233%
LIWANLI Innovation Co., Ltd.	- TWD	-Infinity%
YungShin Global Holding Corporation	929.61 Million TWD	27.392%
PhytoHealth Corporation	-121.67 Million TWD	654.727%
SCI Pharmtech, Inc.	160.3 Million TWD	-321.07%
PharmaEssentia Corporation	- TWD	-Infinity%
Bora Pharmaceuticals Co., LTD.	5.24 Billion TWD	87.141%

Global Stocks Search

Formosa Laboratories, Inc. (4746.TW)

Operating Income Summary of Formosa Laboratories, Inc.

Annual Operating Income Chart of Formosa Laboratories, Inc. (2023 - 2009)

Historical Annual Operating Income of Formosa Laboratories, Inc. (2023 - 2009)

Peer Operating Income Comparison of Formosa Laboratories, Inc.